A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Pfizer3,800 enrolled

Overview

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.

For additional information please call: 1-800-718-1021

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

3,800

Conditions

Hyperlipidemia

Interventions

torcetrapib/atorvastatinDRUG

atorvastatinDRUG

placeboDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * subjects with elevated cholesterol Exclusion Criteria: * Women who are pregnant or lactating, or planning to become pregnant. * Intolerance to statin therapy resulting in withdrawal * Subjects taking any drugs known to be associated with an increased risk of myositis in combination with HMG-CoA reductase inhibitors * Subjects with any other medical condition or laboratory abnormality which could affect subject safety, preclude evaluation of response, or render unlikely that the subject would complete the study

Locations (154)

Outcomes

Primary Outcomes

LDL and HDL levels

Secondary Outcomes

other lipid parameters

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Pfizer Investigational Site

Mobile, Alabama, United States

Pfizer Investigational Site

Mesa, Arizona, United States

Pfizer Investigational Site

Oro Valley, Arizona, United States

Pfizer Investigational Site

Phoenix, Arizona, United States

Pfizer Investigational Site

Sun City, Arizona, United States

Pfizer Investigational Site

Little Rock, Arkansas, United States

Pfizer Investigational Site

Anaheim, California, United States

Pfizer Investigational Site

Carmichael, California, United States

Pfizer Investigational Site

Concord, California, United States

Pfizer Investigational Site

Greenbrae, California, United States

...and 144 more locations